Clinical outcomes in higher-order multiples reduced to dichorionic diamniotic (DCDA) twins compared with primary twins and singletons: A prospective observational study.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Jun 2022
Historique:
revised: 18 08 2021
received: 10 06 2021
accepted: 26 09 2021
pubmed: 31 8 2021
medline: 18 5 2022
entrez: 30 8 2021
Statut: ppublish

Résumé

To compare outcomes in higher-order multiple pregnancies reduced to dichorionic diamniotic (DCDA) twins with primary DCDA twins and singleton pregnancies. This prospective observational study included all higher-order multiple pregnancies that underwent ultrasound-guided transabdominal fetal reduction at 11-13 weeks of gestation from January 2018 to June 2020. Outcomes were compared with 100 primary DCDA twins and 1078 singletons. Sixty-four higher-order multiples underwent reduction at mean gestational age of 11.46 weeks. Of the reduced pregnancies, 3.12% resulted in miscarriage before 24 weeks compared with 2% (2/100) of primary twins and 0.74% of singletons (P = 0.09). The mean gestational age at delivery was 33.48 weeks for reduced twins, 34.52 weeks for primary twins (P = 0.10) and 38.14 weeks for singletons (P < 0.001). Compared with primary twins, the adjusted odds of preterm delivery before 34 weeks and before 36 weeks for reduced twins were 0.56 (95% confidence interval [CI] 0.48-3.54, P = 0.62) and 0.84 (95% CI 0.78-8.85, P = 0.08), respectively. There was no significant difference in rates of pre-eclampsia, Cesarean delivery, birth weight below the 10th and 3rd centiles, and perinatal mortality among primary and reduced twins. All risks were significantly lower in singleton pregnancies. Reduced twins have similar obstetric and perinatal outcomes as primary twins, but adverse outcomes are significantly higher in both groups when compared with singleton pregnancies.

Identifiants

pubmed: 34460958
doi: 10.1002/ijgo.13901
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

671-676

Informations de copyright

© 2021 International Federation of Gynecology and Obstetrics.

Références

Committee on Ethics. Multifetal pregnancy reduction. Committee opinion no. 719. Obstet Gynecol. 2017;130:e158-63.
Satija M, Sharma S, Soni RK, Sachar RK, Singh GP. Twinning and its correlates: community-based study in a rural area of India. Hum Biol. 2008;80(6):611-621.
Gupta P, Faridi MM, Goel N, Zaidi ZH. Reappraisal of twinning: epidemiology and outcome in the early neonatal period. Singapore Med J. 2014;55(6):310-317.
National Institute for Health and Care Excellence. Twin and triplet pregnancy [Nice Guideline No. 137]. 2019. https://www.nice.org.uk/guidance/ng137
American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Multifetal gestations: twin, triplet, and higher-order multifetal pregnancies. ACOG Practice bulletin no. 144. Obstet Gynecol. 2014;123:1118-1132.
Salomon LJ, Alfirevic Z, Bilardo CM, et al. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2013;41(1):102-113.
Khalil A, Rodgers M, Baschat A, et al. ISUOG Practice Guidelines: role of ultrasound in twin pregnancy. Ultrasound Obstet Gynecol. 2016;47(2):247-263. Erratum in: Ultrasound Obstet Gynecol. 2018 Jul;52(1):140.
Dodd JM, Dowswell T, Crowther CA. Reduction of the number of fetuses for women with a multiple pregnancy. Cochrane Database Syst Rev. 2015;11:CD003932.
Anthoulakis C, Dagklis T, Mamopoulos A, Athanasiadis A. Risks of miscarriage or preterm delivery in trichorionic and dichorionic triplet pregnancies with embryo reduction versus expectant management: a systematic review and meta-analysis. Hum Reprod. 2017;32(6):1351-1359.
Evans MI, Andriole S, Britt DW. Fetal reduction: 25 years’ experience. Fetal Diagn Ther. 2014;35(2):69-82.
Papageorghiou AT, Avgidou K, Bakoulas V, Sebire NJ, Nicolaides KH. Risks of miscarriage and early preterm birth in trichorionic triplet pregnancies with embryo reduction versus expectant management: new data and systematic review. Hum Reprod. 2006;21:1912-1917.
Ata B, Rasillo LJ, Sukhdeo S, Son WY, Tan SL, Dahan MH. Obstetric out- comes of IVF trichorionic triamniotic triplets which are spontaneously or electively reduced to twins. J Assist Reprod Genet. 2011;28:1217-1222.
Chaveeva P, Kosinski P, Puglia D, Poon LC, Nicolaides KH. Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management. Fetal Diagn Ther. 2013;34(4):199-205.
Wimalasundera RC. Selective reduction and termination of multiple pregnancies. Semin Fetal Neonatal Med. 2010;15:327-335.
Evans MI, Berkowitz RL, Wapner RJ, et al. Improvement in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol. 2001;184(2):97-103.
van de Mheen L, Everwijn SMP, Knapen MFCM, et al. The effectiveness of multifetal pregnancy reduction in trichorionic triplet gestation. Am J Obstet Gynecol. 2014;210(536):e1-6.
Običan S, Brock C, Berkowitz R, Wapner RJ. Multifetal pregnancy reduction. Clin Obstet Gynecol. 2015;58(3):574-584.
FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health. Ethical recommendations on multiple pregnancy and multifetal reduction. Int J Gynaecol Obstet. 2006;92(3):331-332.

Auteurs

Chanchal Singh (C)

Department of Fetal Medicine, Madhukar Rainbow Children's Hospital, New Delhi, India.

Seema Thakur (S)

Department of Medical Genetics and Fetal Medicine, Madhukar Rainbow Children's Hospital, New Delhi, India.

Gazala Shahnaz (G)

Department of Fetal Medicine, Madhukar Rainbow Children's Hospital, New Delhi, India.

Savita Dagar (S)

Department of Fetal Medicine, Madhukar Rainbow Children's Hospital, New Delhi, India.

Aditi Shastri (A)

Department of Fetal Medicine, Madhukar Rainbow Children's Hospital, New Delhi, India.

Deeksha Khurana (D)

Indian Institute of Public Health, Public Health Foundation of India, Bengaluru, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH